Shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) gapped up prior to trading on Wednesday . The stock had previously closed at $1.27, but opened at $1.36. Corindus Vascular Robotics shares last traded at $1.65, with a volume of 3788088 shares.
Separately, Zacks Investment Research lowered shares of Corindus Vascular Robotics from a “buy” rating to a “hold” rating in a research note on Friday, January 12th. Three investment analysts have rated the stock with a sell rating and two have issued a buy rating to the stock. Corindus Vascular Robotics has a consensus rating of “Hold” and an average price target of $2.33.
The firm has a market capitalization of $272.68, a P/E ratio of -5.67 and a beta of 18.81.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its holdings in Corindus Vascular Robotics by 4.6% during the fourth quarter. BlackRock Inc. now owns 4,384,539 shares of the medical equipment provider’s stock worth $4,428,000 after buying an additional 191,134 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Corindus Vascular Robotics by 57.6% during the second quarter. Vanguard Group Inc. now owns 3,279,185 shares of the medical equipment provider’s stock worth $6,100,000 after buying an additional 1,198,384 shares in the last quarter. Millennium Management LLC purchased a new stake in Corindus Vascular Robotics during the fourth quarter worth $2,189,000. Essex Investment Management Co. LLC lifted its holdings in Corindus Vascular Robotics by 55.2% during the fourth quarter. Essex Investment Management Co. LLC now owns 1,238,664 shares of the medical equipment provider’s stock valued at $1,251,000 after purchasing an additional 440,601 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Corindus Vascular Robotics by 42.4% during the second quarter. Northern Trust Corp now owns 959,920 shares of the medical equipment provider’s stock valued at $1,786,000 after purchasing an additional 285,811 shares in the last quarter.
WARNING: This story was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://ledgergazette.com/2018/03/14/corindus-vascular-robotics-cvrs-shares-gap-up-to-1-36.html.
About Corindus Vascular Robotics
Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.